Viewing Study NCT01279850


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-28 @ 11:29 AM
Study NCT ID: NCT01279850
Status: COMPLETED
Last Update Posted: 2023-10-10
First Post: 2011-01-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-08
Start Date Type: ACTUAL
Primary Completion Date: 2017-07
Primary Completion Date Type: ACTUAL
Completion Date: 2017-07
Completion Date Type: ACTUAL
First Submit Date: 2011-01-18
First Submit QC Date: None
Study First Post Date: 2011-01-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-07-23
Results First Submit QC Date: None
Results First Post Date: 2019-05-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-26
Last Update Post Date: 2023-10-10
Last Update Post Date Type: ACTUAL